Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Radiotherapy, Conformal × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 3 Lung Neoplasms 3 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Adenocarcinoma, Bronchiolo-Alveolar 2 Adenocarcinoma of Lung 2 Solitary Fibrous Tumor, Pleural 1 Rectal Neoplasms 1 Radiodermatitis 1 Pancreatic Intraductal Neoplasms 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuroblastoma 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma, Malignant 1 Inflammation 1 Germinoma 1 Ganglioneuroblastoma 1 Extensive Stage Small Cell Lung Carcinoma 1 Ependymoma 1 Diabetes Insipidus 1 Central Nervous System Nongerminomatous Germ Cell Tumor 1 Central Nervous System Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Brain Neoplasms 1 Astrocytoma 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡